Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

MS Aapro; Heidy Wijk; MEL Burg; WW ten Bokkel Huinink; I Vergote; JP Guastalla; R Rosso; A Kobierska; LVAM Beex; M Namer; Ted Splinter; JB Vermorken

doi:10.1016/S0959-8049(03)00198-9

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

MS Aapro, Heidy Wijk, MEL Burg, WW ten Bokkel Huinink, I Vergote, JP Guastalla, R Rosso, A Kobierska, LVAM Beex, M Namer, Ted Splinter, JB Vermorken

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

1 Citation (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1141-1143
Number of pages	3
Journal	European Journal of Cancer
Volume	39
DOIs	https://doi.org/10.1016/S0959-8049(03)00198-9
Publication status	Published - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0959-8049(03)00198-9

http://hdl.handle.net/1765/74085

Cite this

Aapro, MS., Wijk, H., Burg, MEL., ten Bokkel Huinink, WW., Vergote, I., Guastalla, JP., Rosso, R., Kobierska, A., Beex, LVAM., Namer, M., Splinter, T., & Vermorken, JB. (2003). Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. European Journal of Cancer, 39, 1141-1143. https://doi.org/10.1016/S0959-8049(03)00198-9

@article{d212976c23054f48b8e4bdb475603517,

title = "Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group",

author = "MS Aapro and Heidy Wijk and MEL Burg and {ten Bokkel Huinink}, WW and I Vergote and JP Guastalla and R Rosso and A Kobierska and LVAM Beex and M Namer and Ted Splinter and JB Vermorken",

year = "2003",

doi = "10.1016/S0959-8049(03)00198-9",

language = "Undefined/Unknown",

volume = "39",

pages = "1141--1143",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

}

Aapro, MS, Wijk, H, Burg, MEL, ten Bokkel Huinink, WW, Vergote, I, Guastalla, JP, Rosso, R, Kobierska, A, Beex, LVAM, Namer, M, Splinter, T & Vermorken, JB 2003, 'Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group', European Journal of Cancer, vol. 39, pp. 1141-1143. https://doi.org/10.1016/S0959-8049(03)00198-9

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group. / Aapro, MS; Wijk, Heidy; Burg, MEL; ten Bokkel Huinink, WW; Vergote, I; Guastalla, JP; Rosso, R; Kobierska, A; Beex, LVAM; Namer, M; Splinter, Ted; Vermorken, JB.

In: European Journal of Cancer, Vol. 39, 2003, p. 1141-1143.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

AU - Aapro, MS

AU - Wijk, Heidy

AU - Burg, MEL

AU - ten Bokkel Huinink, WW

AU - Vergote, I

AU - Guastalla, JP

AU - Rosso, R

AU - Kobierska, A

AU - Beex, LVAM

AU - Namer, M

AU - Splinter, Ted

AU - Vermorken, JB

PY - 2003

Y1 - 2003

U2 - 10.1016/S0959-8049(03)00198-9

DO - 10.1016/S0959-8049(03)00198-9

M3 - Article

VL - 39

SP - 1141

EP - 1143

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

ER -